Xtx Topco LTD Mirati Therapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $143,353 - $212,965	3,414 New	3,414 $200,000
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $201,302 - $400,825	-2,655 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $350,486 - $505,219	2,655 New	2,655 $389,000
Q2 2021 Aug 12, 2021	SELL	$144.0 - $179.73 $453,600 - $566,149	-3,150 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $500,597 - $698,071	3,150 New	3,150 $540,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.